Apyx Medical (APYX) Return on Capital Employed (2011 - 2026)

Apyx Medical's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 7.68% for Q1 2026.

• Quarterly Return on Capital Employed rose 2116.0% year-over-year to 7.68% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.68% (up 2116.0% YoY) and the FY2025 annual result came in at 11.82%, up 1891.0% from the prior year.
• Return on Capital Employed was 7.68% for Q1 2026 at Apyx Medical, up from 12.7% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 7.68% in Q1 2026 and bottomed at 65.17% in Q1 2023.
• A 5-year average of 33.94% and a median of 34.39% in 2023 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2023 — Return on Capital Employed tumbled 3647 bps — and 2024, when it jumped 3682 bps.
• Apyx Medical's Return on Capital Employed stood at 56.54% in 2022, then surged by 46 bps to 30.49% in 2023, then fell by 19 bps to 36.2% in 2024, then surged by 65 bps to 12.7% in 2025, then surged by 40 bps to 7.68% in 2026.
• Business Quant data shows APYX's Return on Capital Employed at 7.68% in Q1 2026, 12.7% in Q4 2025, and 20.31% in Q3 2025.